Paul Jansen

Paul Jansen is a highly experienced professional with a strong background in drug and biologics device development, including registration, CMC, manufacturing, quality, and business development.

He has excelled in cross-cultural work environments in Japan and the EU, showcasing exceptional project management skills and the ability to think strategically, creatively, and tactically to ensure thoughtful plans translate into coordinated action.

As a strong leader, Paul has successfully navigated through challenging situations, earning respect from peers and achieving results through effective relationship management internally and through alliances.

His educational background includes a Bachelor of Applied Science in Mechanical Engineering with a focus on fluid mechanics from the University of Toronto, as well as a Master of Science in Biomedical/Medical Engineering from the same institution.

Paul Jansen has held various key positions in distinguished organizations, including serving as a Device & Drug Device Consultant, Board Member at Haselmeier Group and Subcuject ApS, Associate Vice President of Medical Device Development, and Global Head of Medical Devices Development at Sanofi.

His extensive professional experience also includes leadership roles at Eli Lilly, such as Project Leader for Alternative Delivery Devices Byetta, COO of Prozac Global Product Team, Global Supply Chain Steward for the Parenteral Network, and various managerial positions in device delivery systems and analytical laboratories.

Prior to his tenure at Eli Lilly, Paul held managerial roles at Philips and Husky Injection Molding Systems, where he honed his expertise in customer support operations, global parts, service management, and employee relations.

Throughout his career, Paul Jansen has demonstrated a remarkable ability to drive success in the development and management of medical devices, fostering innovation and strategic growth within the industry.